Management of impotence after treatment of carcinoma of the prostate.
Impotence commonly occurs as a result of treatment of carcinoma of the prostate. We review the etiology, evaluation, and treatment options available for these patients as well as our experience with fifty prostate cancer patients who underwent placement of penile prostheses. Several excellent alternatives are available for patients with impotence resulting from treatment of carcinoma of the prostate.
Telang
D J
DJ
Department of Urology, Henry Ford Hospital, Detroit, MI 48202.
Farah
R N
RN
D003362:Cost-Benefit Analysis; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007267:Injections; D008297:Male; D015917:Penile Prosthesis / Q000191:economics / Q000592:standards; D011471:Prostatic Neoplasms / Q000628:therapy*; D013396:Suction / Q000191:economics / Q000592:standards; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D015016:Yohimbine / Q000494:pharmacology / Q000627:therapeutic use
D014665:Vasodilator Agents; D015016:Yohimbine